Роль клопидогрела во вторичной профилактике ишемического инсульта
https://doi.org/10.21518/2079-701X-2014-5-12-15
Аннотация
Об авторах
К. С. МешковаРоссия
В. В. Гудкова
Россия
Список литературы
1. Бокарев И.Н. Атеросклероз - проблема современности. Тромбоз, гемостаз и реология, 2000, 1: 6-7.
2. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002, 324: 71-86.
3. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment. (TOAST) Investigators: Low molecular weight heparinoid, org 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial. JAMA, 1998, 279: 1265-1272.
4. Easton JD. Antiplatelet agents for stroke prevention Cerebrovasular Disease, 1994, 4 (suppl. 1): 26-32.
5. Haas WK, Easton JD, Adams HP Jr et al. A randomized trial comparing ticlopedine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med, 1989, 321: 501-07.
6. Атарщикова М.В. Клопидогрель (плaвикс) снижает риск развития ишемических осложнений у больных атеросклерозом. Приложение «Инсульт» к Журналу неврологии и психиатрии им. С.С. Корсакова, 2001, 1: 58-65.
7. Savi P, Laplace MC, Maffrand JP, Herbert JM. Binding of (H)-2-methylthio ADP to rat platelets: effect of clopidogrel and ticlopidine. J Pharmacol Exp Ther, 1994, 269: 772-77.
8. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 1996, 348: 1329-39.
9. Jauch EC, Saver JL, Adams HP Jr et al. American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2013, Mar., 44 (3): 870-947. doi: 10.1161/ STR.0b013e318284056a. Epub 2013 Jan 31.
10. Diener HC, Bogousslavsky J, Brass LM et al. MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial. Lancet, 2004, 364: 331-37.
11. Amarenco P, Donnan GA. Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin? Stroke, 2004, 35: 2606-08.
12. Rothwell PM. Lessons from MATCH for future randomised trials in secondary prevention of stroke. Lancet, 2004, 364: 305-07.
13. Yongjun Wang, Yilong Wang, Xingquan Zhao et al. for the CHANCE Investigators. Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack. N Engl J Med, 2013, 369: 11-19 July 4, 2013. DOI: 10.1056/NEJMoa1215340
14. Deepak L Bhatt, MD, Keith AA et al. for the CHARISMA Investigators Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events. N Engl J Med, 2006, 354: 1706-1717. April 20, 2006. DOI: 10.1056/NEJMoa060989
Рецензия
Для цитирования:
Мешкова К.С., Гудкова В.В. Роль клопидогрела во вторичной профилактике ишемического инсульта. Медицинский Совет. 2014;(5):12-15. https://doi.org/10.21518/2079-701X-2014-5-12-15
For citation:
Meshkova K.S., Gudkova V.V. Role of clopidogrel role in secondary prevention of ischemic stroke. Meditsinskiy sovet = Medical Council. 2014;(5):12-15. (In Russ.) https://doi.org/10.21518/2079-701X-2014-5-12-15